Delivery Order SPE2DB20D2104-SPE2DB26FMABB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, with a contract value of $6,473.57 and an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing federal contract vehicle. The place of performance is listed as AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens, with a ceiling value of $2,536.02 and a firm fixed price structure. The award, issued on August 8, 2025, with ultimate completion scheduled for August 11, 2025, represents a non-competitive delivery order under the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $3,097.52. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with a ceiling value of $10,014.11 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of June 2, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, valued at $12,000.90. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $4,646.28. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for completion by August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen insulin pens (3 mL) with a ceiling value of $17,358.71 under a firm fixed-price arrangement. The award, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a direct purchase of pharmaceutical supplies with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin products, with a ceiling value of $2,710.33. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is expected to be completed by August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company is headquartered and...
- The Defense Logistics Agency awarded a delivery order valued at $15,528.32 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens. This non-competitive delivery order carries a firm fixed price and is scheduled for completion by September 8, 2025. The award was made to AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, where the products will be supplied from. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $18,615.24 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This competitive award, issued on May 23, 2025, with completion targeted for May 27, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMABBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, with a ceiling value of $1,548.76. This is a firm fixed price delivery order with an ultimate completion date of October 16, 2025, executed without a set-aside designation, indicating competitive award. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications and medical supplies to support military healthcare programs worldwide. The Humulin R insulin product delivery supports the Defense Health Agency and other federal healthcare systems' pharmaceutical supply needs, representing routine medical procurement within AmerisourceBergen's established federal contract portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/15/25 |